Evidence map›Paper›PMID 22685279›Full record

ArticleJournal of bacteriology2012

Synthesis of lipoteichoic acids in Bacillus anthracis.

Gabriella Garufi, Antoni P Hendrickx, Karen Beeri, Justin W Kern, Anshika Sharma, Stefan G Richter, Olaf Schneewind, Dominique Missiakas

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Structure-Based Discovery of Lipoteichoic Acid Synthase Inhibitors.Journal of chemical information and modeling · 2022
    Article
  4. Article
  5. Disruption of protein rhamnosylation affects theCell surface (Amsterdam, Netherlands) · 2021
    Article
  6. Article
  7. Review
  8. TheMicroorganisms · 2020
    Review
  9. Article
  10. Pyruvate Substitutions on Glycoconjugates.International journal of molecular sciences · 2019
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Gabriella GarufiHoward Taylor Ricketts Laboratory, Argonne National Laboratory, Argonne, Illinois, USA.
Antoni P Hendrickx
Karen Beeri
Justin W Kern
Anshika Sharma
Stefan G Richter
Olaf Schneewind
Dominique Missiakas
Argonne National Laboratory · USUniversity of Chicago · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI SHUMAN, HOWARD A · 2003 to 2013
$87.6M
Molecular And Cellular Biology Training ProgramT32GM007183 · NIGMS · UNIVERSITY OF CHICAGO · PI GLICK, BENJAMIN S, RICE, PHOEBE A · 1985 to 2021
$23.9M
Surface Proteins of Bacillus anthracisR01AI069227 · NIAID · UNIVERSITY OF CHICAGO · PI Dominique Missiakas · 2007 to 2026
$6.5M
NIAID NIH HHS 1-U54-AI-057153NIAID NIH HHS U54 AI057153NIGMS NIH HHS GM007183NIGMS NIH HHS T32 GM007183
6 · The paper itself

Abstract

Lipoteichoic acid (LTA), a glycerol phosphate polymer, is a component of the envelope of Gram-positive bacteria that has hitherto not been identified in Bacillus anthracis, the causative agent of anthrax. LTA synthesis in Staphylococcus aureus and other microbes is catalyzed by the product of the ltaS gene, a membrane protein that polymerizes polyglycerol phosphate from phosphatidyl glycerol. Here we identified four ltaS homologues, designated ltaS1 to -4, in the genome of Bacillus anthracis. Polyglycerol phosphate-specific monoclonal antibodies were used to detect LTA in the envelope of B. anthracis strain Sterne (pXO1(+) pXO2(-)) vegetative forms. B. anthracis mutants lacking ltaS1, ltaS2, ltaS3, or ltaS4 did not display defects in growth or LTA synthesis. In contrast, B. anthracis strains lacking both ltaS1 and ltaS2 were unable to synthesize LTA and exhibited reduced viability, altered envelope morphology, aberrant separation of vegetative forms, and decreased sporulation efficiency. Expression of ltaS1 or ltaS2 alone in B. anthracis as well as in other microbes was sufficient for polyglycerol phosphate synthesis. Thus, similar to S. aureus, B. anthracis employs LtaS enzymes to synthesize LTA, an envelope component that promotes bacterial growth and cell division.

Indexed as

Bacillus anthracisCell WallGene DeletionGenes, BacterialLipopolysaccharidesMicrobial ViabilitySpores, BacterialTeichoic AcidsTransferases (Other Substituted Phosphate Groups)Lipopolysaccharideslipoteichoic acidpolyglycerol phosphate polymeraseTeichoic AcidsTransferases (Other Substituted Phosphate Groups)

Identifiers

PMID22685279
PMCPMC3416223
OpenAlexW2167171118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.